Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Volume-based quantitative FDG PET/CT metrics and their association with optimal debulking and progression-free survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery
Ist Teil von
European radiology, 2015-11, Vol.25 (11), p.3348-3353
Ort / Verlag
Berlin/Heidelberg: Springer Berlin Heidelberg
Erscheinungsjahr
2015
Quelle
MEDLINE
Beschreibungen/Notizen
Objective
Our aim was to evaluate the associations between quantitative
18
F-fluorodeoxyglucose positron-emission tomography (FDG-PET) uptake metrics, optimal debulking (OD) and progression-free survival (PFS) in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery.
Methods
Fifty-five patients with recurrent ovarian cancer underwent FDG-PET/CT within 90 days prior to surgery. Standardized uptake values (SUV
max
), metabolically active tumour volumes (MTV), and total lesion glycolysis (TLG) were measured on PET. Exact logistic regression, Kaplan-Meier curves and the log-rank test were used to assess associations between imaging metrics, OD and PFS.
Results
MTV (
p
= 0.0025) and TLG (
p
= 0.0043) were associated with OD; however, there was no significant association between SUV
max
and debulking status (
p
= 0.83). Patients with an MTV above 7.52 mL and/or a TLG above 35.94 g had significantly shorter PFS (
p
= 0.0191 for MTV and
p
= 0.0069 for TLG). SUV
max
was not significantly related to PFS (
p
= 0.10). PFS estimates at 3.5 years after surgery were 0.42 for patients with an MTV ≤ 7.52 mL and 0.19 for patients with an MTV > 7.52 mL; 0.46 for patients with a TLG ≤ 35.94 g and 0.15 for patients with a TLG > 35.94 g.
Conclusion
FDG-PET metrics that reflect metabolic tumour burden are associated with optimal secondary cytoreductive surgery and progression-free survival in patients with recurrent ovarian cancer.
Key Points
• Both TLG and MTV were associated with optimal tumour debulking.
• There was no significant association between
SUV
max
and tumour debulking status.
• Patients with higher MTV and/or TLG had significantly shorter PFS.
•
SUV
max
was not significantly related to PFS.